TAMIFEN

This brand name is authorized in Cyprus, Hong Kong SAR China, Tunisia.

Active ingredients

The drug TAMIFEN contains one active pharmaceutical ingredient (API):

1	Tamoxifen UNII 094ZI81Y45 - TAMOXIFEN
	Tamoxifen is a non-steroidal, triphenylethylene-based drug which displays a complex spectrum of oestrogen antagonist and oestrogen agonist-like pharmacological effects in different tissues.
	Read more about Tamoxifen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TAMIFEN Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02BA01	Tamoxifen	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BA Anti-estrogens
Discover more medicines within L02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
HK	Department of Health Drug Office	40706
TN	Direction de la Pharmacie et du Médicament	6973091, 6973092